2052128-15-9 - Names and Identifiers
2052128-15-9 - Physico-chemical Properties
Molecular Formula | C31H34N4O2
|
Molar Mass | 494.63 |
Density | 1.157±0.06 g/cm3(Predicted) |
Boling Point | 717.7±60.0 °C(Predicted) |
Solubility | DMSO : 83.33 mg/mL (168.47 mM; Need ultrasonic) |
pKa | 14.20±0.40(Predicted) |
Storage Condition | -20°C |
In vitro study | H3B-5942 targeting Cys530, both wild-type and mutant ERα were inactivated. Once bound to ERα, the H3B-5942 allows the DNA-binding domain of ERα to bind to the promoter and enhancer regions containing the ERE, inducing ERα to transition to a transcriptionally repressed conformation via the coactivator. In a series of containing ER alpha. |
In vivo study | In the expression of Er alpha. |
2052128-15-9 - Preparation solution concentration reference
| 1mg | 5mg | 10mg |
---|
1 mM | 2.022 ml | 10.109 ml | 20.217 ml |
5 mM | 0.404 ml | 2.022 ml | 4.043 ml |
10 mM | 0.202 ml | 1.011 ml | 2.022 ml |
5 mM | 0.04 ml | 0.202 ml | 0.404 ml |
Last Update:2024-01-02 23:10:35
2052128-15-9 - Reference Information
biological activity | H3B-5942 is a selective, irreversible, ERα WT and ERα mutants were inactivated with Ki values of 1 nM and 0.41 nM, respectively. |
Target | Value |
ERα (Y537S)
()
| 0.41 nM(Ki) |
ERα WT
()
| 1 nM(Ki) |
Last Update:2024-04-10 22:29:15